Orexo AB (publ) (ORXOF)
OTCMKTS · Delayed Price · Currency is USD
2.900
+0.350 (13.73%)
At close: Sep 26, 2025
Orexo AB Market Cap
Orexo AB has a market cap or net worth of $102.35 million as of October 24, 2025. Its market cap has increased by 121.63% in one year.
Market Cap
102.35M
Enterprise Value
143.43M
Revenue
57.68M
Ranking
n/a
PE Ratio
n/a
Stock Price
$2.90
Market Cap Chart
Since November 9, 2005, Orexo AB's market cap has decreased from 105.56M to 102.35M, a decrease of -3.04%. That is a compound annual growth rate of -0.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 102.35M | 87.22% |
| Dec 30, 2024 | 54.67M | 3.62% |
| Dec 29, 2023 | 52.76M | -15.15% |
| Dec 30, 2022 | 62.18M | -52.51% |
| Dec 30, 2021 | 130.93M | -37.43% |
| Dec 30, 2020 | 209.26M | -10.52% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 806.69M |
| Elite Pharmaceuticals | 670.91M |
| Glass House Brands | 619.92M |
| Northwest Biotherapeutics | 371.21M |
| Silence Therapeutics | 344.81M |
| Nika Pharmaceuticals | 335.28M |
| CytoDyn | 327.16M |
| American Oncology Network | 291.52M |